INVYMAB
Live / Allowed — Fourth extension granted (statement of use) (as of 16 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Sept 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98196202
- Mark type
- Stylized text
- Filed
- 25 Sept 2023
- Published for opposition
- 25 Jun 2024
- Attorney of record
- James J. Saul
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances derived from monoclonal antibodies for the treatment and prevention of infectious diseases; chemical, biochemical and microbial products, namely, monoclonal antibodies being pharmaceutical preparations for the treatment and prevention of infectious diseases
Owner
- Invivyd, Inc., New Haven, CT, US
- Invivyd, Inc., Waltham, MA, US
Prosecution history
- 17 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jul 2026 — SOU EXTENSION 4 GRANTED
- 16 Jul 2026 — SOU EXTENSION 4 FILED
- 16 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 24 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Dec 2025 — SOU EXTENSION 3 GRANTED
- 23 Dec 2025 — SOU EXTENSION 3 FILED
- 23 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Aug 2025 — SOU EXTENSION 2 GRANTED
- 08 Aug 2025 — SOU EXTENSION 2 FILED
- 08 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2025 — SOU EXTENSION 1 GRANTED
- 13 Feb 2025 — SOU EXTENSION 1 FILED